ROTTERDAM, June 4, 2018 – LyondellBasell (NYSE: LYB), one of the world's largest plastics, chemicals and refining companies, is introducing Purell EP370S, a polypropylene (PP) heterophasic copolymer that allows for the energy efficient production of healthcare articles such as pharmaceutical packaging, labware, medical caps & closures and medical containers. Compared with other PP grades, Purell EP370S maintains its excellent toughness and physical properties at lower conversion temperatures. The high flowability enables also shorter cycle times.
Produced using a non-phthalate catalyst, Purell EP370S offers new opportunities to the healthcare industry. “Purell EP370S offers a good balance between physical and mechanical properties to meet the requirements of our customers in injection molding applications because of its good flowability and impact behavior”, said Rodney Fox, marketing manager of LyondellBasell’s European PP Healthcare and Caps and Closures business.
As all other Purell grades Purell EP370S also benefits from LyondellBasell’s Purell Service Concept, developed for customers in the pharmaceutical and healthcare industry.
LyondellBasell (NYSE: LYB) is one of the largest plastics, chemicals and refining companies in the world. Driven by its 13,400 employees around the globe, LyondellBasell produces materials and products that are key to advancing solutions to modern challenges like enhancing food safety through lightweight and flexible packaging, protecting the purity of water supplies through stronger and more versatile pipes, and improving the safety, comfort and fuel efficiency of many of the cars and trucks on the road. LyondellBasell sells products into approximately 100 countries and is the world's largest licensor of polyolefin technologies. In 2018, LyondellBasell was named to Fortune magazine’s list of the “World’s Most Admired Companies.” More information about LyondellBasell can be found at www.LyondellBasell.com.